NM_000135.4:c.1627-32T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000135.4(FANCA):​c.1627-32T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.013 in 1,592,614 control chromosomes in the GnomAD database, including 504 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 40 hom., cov: 32)
Exomes 𝑓: 0.013 ( 464 hom. )

Consequence

FANCA
NM_000135.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.133

Publications

2 publications found
Variant links:
Genes affected
FANCA (HGNC:3582): (FA complementation group A) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia. [provided by RefSeq, Jul 2008]
FANCA Gene-Disease associations (from GenCC):
  • Fanconi anemia complementation group A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 16-89779989-A-G is Benign according to our data. Variant chr16-89779989-A-G is described in ClinVar as [Benign]. Clinvar id is 255238.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0845 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FANCANM_000135.4 linkc.1627-32T>C intron_variant Intron 17 of 42 ENST00000389301.8 NP_000126.2 O15360-1
FANCANM_001286167.3 linkc.1627-32T>C intron_variant Intron 17 of 42 NP_001273096.1 O15360-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FANCAENST00000389301.8 linkc.1627-32T>C intron_variant Intron 17 of 42 1 NM_000135.4 ENSP00000373952.3 O15360-1

Frequencies

GnomAD3 genomes
AF:
0.0143
AC:
2180
AN:
152202
Hom.:
40
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0175
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00799
Gnomad ASJ
AF:
0.0213
Gnomad EAS
AF:
0.00558
Gnomad SAS
AF:
0.0915
Gnomad FIN
AF:
0.0105
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.00930
Gnomad OTH
AF:
0.0167
GnomAD2 exomes
AF:
0.0195
AC:
4875
AN:
250046
AF XY:
0.0228
show subpopulations
Gnomad AFR exome
AF:
0.0163
Gnomad AMR exome
AF:
0.00521
Gnomad ASJ exome
AF:
0.0182
Gnomad EAS exome
AF:
0.00354
Gnomad FIN exome
AF:
0.0134
Gnomad NFE exome
AF:
0.0103
Gnomad OTH exome
AF:
0.0189
GnomAD4 exome
AF:
0.0128
AC:
18467
AN:
1440294
Hom.:
464
Cov.:
27
AF XY:
0.0151
AC XY:
10820
AN XY:
717984
show subpopulations
African (AFR)
AF:
0.0177
AC:
584
AN:
33030
American (AMR)
AF:
0.00649
AC:
290
AN:
44676
Ashkenazi Jewish (ASJ)
AF:
0.0179
AC:
465
AN:
26018
East Asian (EAS)
AF:
0.00770
AC:
305
AN:
39600
South Asian (SAS)
AF:
0.0831
AC:
7130
AN:
85810
European-Finnish (FIN)
AF:
0.0125
AC:
668
AN:
53400
Middle Eastern (MID)
AF:
0.0419
AC:
239
AN:
5702
European-Non Finnish (NFE)
AF:
0.00717
AC:
7836
AN:
1092342
Other (OTH)
AF:
0.0159
AC:
950
AN:
59716
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1040
2081
3121
4162
5202
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
346
692
1038
1384
1730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0144
AC:
2186
AN:
152320
Hom.:
40
Cov.:
32
AF XY:
0.0153
AC XY:
1138
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.0176
AC:
731
AN:
41578
American (AMR)
AF:
0.00798
AC:
122
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0213
AC:
74
AN:
3470
East Asian (EAS)
AF:
0.00559
AC:
29
AN:
5184
South Asian (SAS)
AF:
0.0915
AC:
442
AN:
4828
European-Finnish (FIN)
AF:
0.0105
AC:
111
AN:
10620
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.00931
AC:
633
AN:
68024
Other (OTH)
AF:
0.0161
AC:
34
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
109
218
328
437
546
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0134
Hom.:
5
Bravo
AF:
0.0118
Asia WGS
AF:
0.0510
AC:
177
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fanconi anemia complementation group A Benign:2
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 08, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 29, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
2.4
DANN
Benign
0.81
PhyloP100
-0.13
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17226337; hg19: chr16-89846397; COSMIC: COSV104699326; API